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Abstract
 .Previously, as a new type of pH-sensitive liposome, we prepared egg yolk phosphatidylcholine EYPC liposomes
 .  .bearing succinylated poly glycidol , that is a poly ethylene glycol derivative having carboxyl groups, and showed that
fusion ability of the liposomes increases under weakly acidic and acidic conditions Kono, K., Zenitani, K. and Takagishi,
 . .T. 1994 Biochim. Biophys. Acta 1193, 1–9 . In this study, we examined intracellular delivery of a water-soluble
 .molecule, calcein, mediated by the succinylated poly glycidol -modified liposomes. When CV-1 cells, an established line of
African green monkey kidney cells, were incubated with bare EYPC liposomes containing calcein at 378C, only weak and
vesicular fluorescence of calcein was observed by using a fluorescence microscope. In contrast, the cells treated with the
polymer-modified liposomes containing calcein displayed more intensive and diffuse fluorescence, indicating that calcein
was transferred into the cytoplasm. Uptake of the polymer-modified liposomes by the cells was shown to decrease slightly
as amount of the polymer fixed on the liposome increases. However, the fluorescence of calcein observed in the
liposome-treated cell was, on the contrary, enhanced as amount of the polymer fixed on the liposome increases, indicating
that the liposome modified with a higher amount of the polymer transfers its content into cytoplasm more efficiently after
 .internalization into the cell. Fusion assay by resonance energy transfer using N- 7-nitrobenz-2-oxa-1,3-diazol-4-yl phos-
phatidylethanolamine and lissamine rhodamine B-sulfonylphosphatidylethanolamine suggested occurrence of fusion be-
tween the polymer-modified liposomes and endosomal andror lysosomal membranes. Moreover, the liposome with a higher
polymer content revealed higher percent fusion after internalization into the cell. These results imply that the polymer-mod-
ified liposomes transfer the content into the cytoplasm by fusing with the endosomal membrane after internalization into the
cells through an endocytic pathway.
 .Keywords: Poly ethylene glycol derivative; pH-sensitive liposome; Cytoplasmic delivery; Membrane fusion; Phosphatidylcholine
 .Abbreviations: SucPG, succinylated poly glycidol ; EYPC, egg yolk phosphatidylcholine; PE, phosphatidylethanolamine; PC,
 . phosphatidylcholine; NBD-PE, N- 7-nitrobenz-2-oxa-1,3-diazol-4-yl phosphatidylethanolamine; Rh-PE, N- lissamine rhodamine B sulfo-
.nyl phosphatidylethanolamine; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; PBS, phosphate-buffered saline;
PBS-CM, phosphate-buffered saline containing calcium and magnesium
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1. Introduction
pH-sensitive liposomes have been developed to
improve efficiency of the cytoplasmic delivery of
various polar molecules and macromolecules and
many studies have shown effectiveness of pH-sensi-
w xtive liposomes as a carrier for these molecules 1,2 .
pH-sensitive liposomes are stable under a neutral
condition, but are destabilized and become fusogenic
under an acidic condition. Therefore, it is thought
that after uptake by cells through an endocytic path-
way, the liposomes exposed to the acidic pH of the
endosome destabilize andror fuse with the endoso-
mal membrane and then release their contents into
the cytoplasm without degradation by the lysosomal
w xenzymes 3 .
So far, a number of pH-sensitive liposomes have
been prepared using unsaturated phos -
 .phatidylethanolamine PE and amphipathic stabiliz-
w xers 4–10 . While their efficiency as a cytoplasmic
delivery system has been shown to be superior to
pH-insensitive liposomes, stability of the liposomes is
relatively poor as compared to phosphatidylcholine
 . w xPC -based liposomes 11,12 . Moreover, it is known
that extensive leakage of contents from the PE-based
w xliposomes occurs during fusion 5,7,9 . These prob-
lems should be attributable partly to their high ten-
dency to revert to the hexagonal II phase.
As another approach for preparing pH-sensitive
liposomes, modification of liposomes with molecules
that generate fusogenic activity depending on pH has
w xbeen attempted 13–15 . It is well known that several
viral fusion proteins, such as hemagglutinin of in-
fluenza virus, induce membrane fusion efficiently
w x16 . Also, fusion peptides of viral proteins and their
synthetic analogs have been shown to reveal fuso-
w xgenic activity similar to the viral proteins 17–19 .
Furthermore, a number of synthetic, amphipathic pep-
w xtides 20–23 have been shown to reveal fusogenic
activity. Because these molecules are able to induce
fusion of vesicles made from PC which form a stable
bilayer membrane, it is possible to prepare fusogenic
liposomes with high stability by conjugating these
molecules to PC-based liposomes. A synthetic, am-
phipathic 30-residue peptide with a repeat unit of
Glu-Ala-Leu-Ala, GALA, was designed by Szoka et
al. to mimic the behaviors of the fusion peptides of
w xviral fusion proteins 24 and they showed that GALA
 .Fig. 1. Structure of succinylated poly glycidol .
induces fusion of PC liposomes in a pH-dependent
w xfashion 20 . Puyal et al. designed a 14-residue
GALA-type peptide-attached liposomes and showed
that intermixing of lipid between the liposomes oc-
w xcurs in a pH-dependent fashion 14 . Recently, Vogel
et al. also prepared liposomes bearing a 30-residue
peptide with a sequence similar to that of GALA and
demonstrated that the liposomes release the content
into cytoplasm after internalization into cells by en-
w xdocytosis 15 .
 .On the other hand, poly ethylene glycol is a
well-known fusogenic polymer and hence, modifica-
tion of liposomes with this polymer is expected to
give the liposomes with ability to fuse. In a previous
w x study 13 , we synthesized succinylated poly glyci-
.  .  .dol SucPG Fig. 1 as a fusogenic polymer with
pH-sensitivity. This polymer has a main chain struc-
 .ture similar to that of poly ethylene glycol . Also this
polymer has carboxyl groups on the side chains. It
was shown that fusion ability of egg yolk phos-
 .phatidylcholine EYPC liposomes bearing the poly-
mer is elevated with decreasing pH because ionized
carboxylate groups on the polymer chain become
protonated and hence the polymer interacts with the
liposomal membrane strongly.
Since fusion ability of SucPG-modified EYPC li-
posomes increases under an acidic condition, it is
expected that after internalization into cells through
an endocytic pathway, the liposomes transfer their
content into the cytoplasm by fusing with the endoso-
mal membranes. Thus, in this study, we examined
whether this novel pH-sensitive liposome is able to
deliver its content into cytoplasm as the conventional
pH-sensitive liposome, namely PE-based one, does.
2. Materials and methods
2.1. Materials
 .Poly epichlorohydrin was purchased from Aldrich
 .Milwaukee, WIS . Egg yolk phosphatidylcholine
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 .EYPC was obtained from Nippon Fat and Oil
 . Tokyo, Japan . Calcein was supplied by Sigma St.
. Louis, MO . Fluorescent lipids, N- 7-nitrobenz-2-
. oxa-1,3-diazol-4-yl phosphatidylethanolamine NBD-
. PE and N- lissamine rhodamine B sulfo-
.  .nyl phosphatidylethanolamine Rh-PE were from
 .Avanti Polar Lipids Birmingham, AL . Dulbecco’s
 .modified Eagle’s medium DMEM was from Nissui
 .Pharmaceutical Tokyo, Japan . Fetal bovine serum
 .  .FBS was from Hyclone Laboratories Logan, UT .
All other reagents were of analytical grade.
2.2. Synthesis of SucPG ha˝ing long alkyl chains
 .Succinylated poly glycidol was synthesized ac-
w xcording to the method previously reported 13 . In
 .brief, poly glycidol was synthesized via the method
w x of Cohen 25 by the conversion of poly epichlorohy-
.drin . The most frequent molecular weight of
 .poly glycidol obtained was estimated to be 4600,
 .taking poly ethylene glycol as a standard by high-
performance liquid chromatography on Asahipak GS-
510 column. SucPG was obtained by the reaction of
 . poly glycidol with succinic anhydride 1.5 equiva-
.lent to hydroxyl groups of the polymer in N,N-di-
methylformamide at 608C for 3 h. Unit mol percent
of succinylated residue in the resultant polymer was
1 determined to be 94 by H-NMR JEOL JNM-GX-
.270 .
Decylamine was attached to SucPG as anchor to
liposomal membranes as follows. SucPG was dis-
solved in water at pH 5. n-Decylamine 0.1 equiva-
. lent to carboxyl groups of SucPG and 1-ethyl-3- 3-
. dimethylaminopropyl carbodiimide 0.1 equivalent to
.carboxyl groups of SucPG were added to the solu-
tion at 48C and the solution was stirred overnight.
The resultant polymer was purified by liquid chro-
matography on a Sephadex LH-20 column using
methanol. Unit mol percent of n-decylamine-attached
residue in the resultant polymer was determined to be
6 by 1H-NMR.
2.3. Cell culture
CV-1 cell, an African green monkey kidney cell
line, was cultured in DMEM supplemented with 10%
 .FBS in a humidifier incubator 5% CO at 378C.2
The cells were maintained in monolayer culture.
2.4. Preparation of SucPG-modified liposomes con-
taining calcein
SucPG-modified liposomes were prepared as pre-
w xviously reported 13 . A dry thin membrane of mix-
ture of EYPC and SucPG was made by evaporation
of solution of the lipid and the polymer in methanol,
and subsequent drying under vacuum. The membrane
was dispersed in aqueous 200 mM calcein solution
 .pH 7.4 and was sonicated for 30 min using a
 .ultrasonic disruptor Tomy Seiko, UD-200 . Free cal-
cein was removed by gel chromatography on a
 .Sephadex G-75 Pharmacia, Sweden column using
 .phosphate-buffered saline PBS consisting of 8 mM
Na HPO , 1.5 mM KH PO , 137 mM NaCl, and 2.72 4 2 4
 .mM KCl pH 7.4 supplemented with 0.36 mM cal-
cium and 0.42 mM magnesium. Bare EYPC liposome
containing calcein was prepared according to the
above procedure using dry membrane of EYPC with-
out the polymer.
2.5. Fluorescence microscopy of cells treated with
liposomes
CV-1 cells grown on cover slips for 24 h were
washed three times with PBS containing 0.36 mM
 .calcium and 0.42 mM magnesium PBS-CM . For
experiments in which chloroquine was used, the ap-
propriate volume of 10 mM chloroquine solution was
added to the original growth medium 1 h prior to the
wash with PBS. Chloroquine was present in all buffers
thereafter.
Cells were incubated with liposomes containing
200 mM calcein at 1.5 mmol lipidrl for 3 h. After
the incubation, the cells were washed 5 times with
PBS-CM and viewed with an Olympus microscope
 .IMT-2 equipped with a phase contrast and epifluo-
rescence with an excitation filter set that produces
excitation in the range 470–500 nm and allows ob-
servation of fluorescence emission in the range 515–
540 nm with a long wave pass dichroic mirror and
barrier filter.
2.6. E˝aluation of liposome uptake by cells
Liposomes containing NBD-PE were prepared via
the above method using EYPCrNBD-PE 95:5,
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.  5.molrmol as the membrane lipids. Cells 5=10
were plated in 25 cm2-flask containing 5 ml of
DMEM-10% FBS 48 h prior to the experiments. The
cells were washed three times with PBS-CM and then
 .incubated with the liposomes 1.0 mM dispersed in
PBS-CM at 378C or 48C for desired periods.
After incubation, cells were washed five times
with PBS-CM and once with PBS and were dis-
lodged by treatment with PBS containing 1 mM
EDTA for 5 min. Fluorescence intensity of NBD-PE
associated with the cell at 525 nm was measured at
excitation wavelength of 450 nm by using a spectro-
 .fluorometer Shimadzu RF-5000 . For calibration, the
fluorescence intensities for the liposome suspensions
alone were also measured. Amount of liposomes
associated with a cell was estimated from the fluores-
cence intensity of a cell using the calibration curve. It
was confirmed that fluorescence intensity of NBD-PE
is proportional to concentration of NBD in the lipid
membrane under the experimental condition, indicat-
ing that self-quenching of NBD-PE is negligible. The
cell number was determined by estimating cell pro-
w xtein concentration by the Lowry assay 26,27 .
2.7. Fluorometric detection of fusion between lipo-
somes and cellular membranes
Fusion between liposomes and cellular membranes
was detected by measuring resonance energy transfer
w xbetween NBD-PE and Rh-PE 28 . Liposomes con-
taining NBD-PE and Rh-PE were prepared via the
above method using EYPCrNBD-PErRh-PE 94:5:1,
. molrmolrmol as the membrane lipids. Cells 5=
5. 210 were plated in 25 cm -flask containing 5 ml of
DMEM-10% FBS 48 h prior to the experiments. The
cells were washed three times with PBS-CM and
 .were incubated with the liposomes 1.0 mM dis-
persed in PBS-CM at 378C or 48C for 3 h.
After the incubation, cells were washed five times
with PBS-CM and once with PBS and were dis-
lodged by exposing the cells to PBS containing 1
mM EDTA for 5 min. Fluorescence emission spectra
associated with the cell suspension irradiated at 450
nm were measured. Fraction of liposomes fused
andror degraded was determined from the fluores-
cence spectra as described in the results and discus-
sion section. We assumed that ratio of fluorescence
intensity of NBD-PE to that of Rh-PE for the lipo-
 .somes taken up by the cells is expressed as Eq. 1 .
NBD NBDRs I =Fq I = 1yF .T 0
Rh Rhr I =Fq I = 1yF 1 .  .T 0
where R represents ratio of NBD-PE fluorescence
intensity at 522 nm to Rh-PE fluorescence intensity
at 586 nm for the liposome-treated cell suspension.
I NBD, I Rh, I NBD, and I Rh are fluorescence intensities0 0 T T
of NBD-PE and Rh-PE associated with the liposome
suspension used for liposome-cell incubation before
and after addition of Triton X-100 final concentra-
.tion 0.24% , respectively. F expresses fraction of
liposomes fused andror degraded in the liposome-
 .treated cells. F value was determined using Eq. 2
 .which is derived from Eq. 1 .
Fs R= I Rh y I NBD .0 0
Rh Rh NBD NBDr R= I y I y I y I 2 . .  .0 T 0 T
Autofluorescence and influence of addition of the
detergent were corrected from these values.
For observation using a fluorescence microscope,
incubation of cells was performed as mentioned above
except that cells were grown on cover slips. After
incubation with liposomes containing NBD-PE and
 .Rh-PE 1.5 mM for 3 h, the cells were washed 5
times with PBS-CM and viewed with the microscope
with an excitation filter set that produces excitation in
the range of 470–500 nm and allows observation of
fluorescence emission above 515 nm.
2.8. Other methods
The phospholipid concentration was determined by
an assay using Phospholipids B-Test Wako reagent
 .supplied by Wako Osaka, Japan . The size of the
vesicles was measured by dynamic light scattering
 .Otsuka Electronics, DLS-700 .
3. Results and discussion
3.1. Deli˝ery of calcein into CV-1 mediated by
SucPG-modified liposomes
Previously, we demonstrated that fusion ability of
EYPC liposomes modified with SucPG increases be-
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 .  .Fig. 2. Fluorescence micrographs left and phase contrast micrographs right of CV-1 cells treated with various EYPCrSucPG
 .  .  .  .  .liposomes containing calcein. Ratios of EYPC to SucPG wrw for the liposomes are 10:0 A , 9:1 B , 8:2 C , and 7:3 D . The
cell-liposome incubation was performed in phosphate-buffered saline containing calcium and magnesium for 3 h at 378C. The
concentration of liposomal lipid in the incubation was 1.5 mM. Time of exposure to photographic film for these fluorescence micrographs
was 28 s.
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w xlow pH 6 13 . Therefore, it was expected that after
uptake by cells through an endocytic pathway, the
polymer-modified liposomes transfer their contents
into the cytoplasm by fusing with the endosomal
membrane. Thus, the polymer-modified liposome-
mediated delivery of a membrane-impermeable
molecule, calcein, into cells was examined. Here, we
chose CV-1 because interaction of the cell with lipo-
w xsomes has been well characterized 29–31 .
Fusion ability of SucPG-modified liposomes under
an acidic condition has been shown to increase with
w xincreasing amount of the polymer 13 . Therefore, if
the polymer-modified liposomes transfer the content
by fusing with endosome, efficiency of cytoplasmic
delivery by the liposomes is expected to depend on
the amount of the polymer fixed on the liposomes. In
w xthe previous study 13 it was shown that liposomes
prepared from a mixture of SucPG and EYPC with a
 .ratio of up to 3:7 wrw carries the polymer supplied
quantitatively and tightly. Thus, four kinds of lipo-
somes consisting of EYPC and SucPG in the ratio of
 .10:0, 9:1, 8:2, 7:3 wrw were prepared. Mean diam-
eters of these liposomes were estimated to be 40.1,
40.3, 44.9, and 47.9 nm, respectively, by dynamic
light scattering. The diameter increased slightly as the
polymer content increased. Since we used
 .poly glycidol with peak molecular weight of 4600,
 .Fig. 3. Uptake kinetics for SucPGrEYPC 7:3, wrw liposome
by CV-1 cell in phosphate-buffered saline containing calcium and
 .  .magnesium at 378C v and at 08C ’ . The concentration of
liposomal lipid in the cell-liposome incubation was 1.0 mM. The
experiments at 378C and at 08C were done in triplicate and in
duplicate, respectively.
Fig. 4. Influence of SucPG content in the liposomal membrane on
uptake by CV-1 cell. The cell-liposome incubation was per-
formed in phosphate-buffered saline containing calcium and mag-
nesium for 3 h at 378C. The concentration of liposomal lipid in
the incubation was 1.0 mM. The experiments were done in
triplicate.
molecular weight of SucPG can be calculated to be
ca. 10000. It is likely that fixation of the polymer
onto the liposome increases apparent size of the
liposome.
Fig. 2 shows fluorescence and phase contrast mi-
crographs of CV-1 cells treated with these liposomes
containing calcein. When the cells were incubated
with the bare EYPC liposome, weak and vesicular
fluorescence of calcein was observed. Similarly,
vesicular fluorescence was seen in the cells after
incubation with an aqueous calcein solution data not
.shown . In contrast, when the cells were treated with
the SucPG-modified liposomes, fluorescence seen in
the cells was quite different. The cells treated with
 .EYPCrSucPG 7:3 liposomes displayed strong and
diffuse fluorescence of calcein. This result suggests
that calcein molecules were transferred into cyto-
plasm for the cells treated with the SucPG-modified
liposome, whereas calcein molecules existed in endo-
some andror lysosome for the cells treated with the
bare liposome or with calcein solution. Moreover, the
cells exhibited more intensive fluorescence when the
cells were treated with the liposome with a higher
content of the polymer, suggesting that the liposome
with a higher amount of the polymer delivers the
content into cytoplasm more efficiently.
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Fig. 3 shows the uptake kinetics for the SucPG-
modified liposome by the cells. The amount of the
liposome associated with the cells is constant and
independent of time when the incubation is per-
formed at 08C. Since endocytosis is inhibited at 08C,
the liposome is likely to bind onto the cell membrane
under this condition. In contrast, at 378C the amount
of liposome associated with the cell increases with
time, indicating that the liposome is taken up by the
cell through an endocytic pathway at 378C, as shown
w xin previous studies 29–31 .
As mentioned above, delivery of calcein is af-
fected by SucPG content of the liposome. Therefore,
influence of the polymer content on uptake by the
cell was examined. The result is shown in Fig. 4. The
amount of the liposome taken up by the cells appears
to decrease slightly as the polymer content in the
liposomal membrane increases. Since surface of the
liposome bearing a higher amount of the polymer
should be covered more effectively by the highly
hydrophilic polymer chains, the polymer chains at-
tached on the liposome surface might reduce interac-
tion between the liposome and the cell and suppress
uptake by the cell. Also, difference in diameter of the
liposome may affect uptake by the cells, although the
difference is not significant.
As shown in Fig. 4, the bare liposome-treated cells
contained the highest amount of the liposome among
these liposome-treated cells. Nevertheless, the bare
liposome-treated cells displayed much weaker fluo-
rescence of calcein than the cells treated with the
polymer-modified liposomes as shown in Fig. 2.
Already, we showed that the modification of the
polymer hardly affect the captured volume of the
w xliposomes 13 . Therefore, it is considered that most
calcein molecules were still trapped and self-quenched
in the bare liposome in the cell. On the contrary,
 .SucPGrEYPC 3:7 liposome-treated cells contained
the lowest amount of the liposome, but displayed the
most intensive fluorescence, suggesting that the lipo-
some can transfer their content into the cytoplasm
most efficiently.
3.2. Fusion between SucPG-modified liposomes and
endosomalr lysosomal membranes
We expected that the liposomes, after uptake by
cells through an endocytic pathway, deliver the con-
tent into cytoplasm by fusing with endosomal andror
lysosomal membranes because the inside of these
compartments is acidic. In fact, CV-1 cells treated
with the SucPG-modified liposomes containing cal-
cein exhibited diffuse fluorescence, indicating calcein
molecules were transferred into cytoplasm. If the
polymer-modified liposomes transfer their content
into the cytoplasm by fusing with the endosomal
andror lysosomal membranes, transfer of calcein
from the endosome into the cytoplasm will be inter-
fered in the presence of chloroquine because it effec-
tively elevates the endosomal and lysosomal pH
w x32,33 and hence will prevent the liposomes from
becoming fusogenic.
Fig. 5 depicts fluorescence and phase contrast
micrographs of CV-1 cells treated with EYPCrSucPG
 .7:3 liposome containing calcein in the presence of
chloroquine. Apparently, fluorescence intensity of
calcein observed in the cells is significantly reduced
in the presence of chloroquine, compared with that in
the absence of chloroquine shown in Fig. 2, although
the fluorescence does not disappear completely. Be-
cause fusion ability of the SucPG-modified liposomes
w xincreases with decreasing pH from neutral pH 13 ,
under even slightly acidic condition the liposomes
become fusogenic to some extent and hence, some
fraction of the liposomes might be destabilized and
fuse with the endosomal andror lysosomal mem-
branes. Alternatively, there may be another pathway
to deliver calcein into cells, such as direct fusion
between the plasma membrane and the liposomes.
However, this result indicates that at least predomi-
nant pathway for generation of calcein fluorescence
requires an acidic environment.
Connor and Huang reported that when L929 cells
were treated with calcein-loaded liposomes composed
of dioleoylphosphatidylethanolamine and palmitoyl-
homocysteine, namely pH-sensitive liposome of con-
ventional type, vesicular fluorescence of calcein was
observed in the cells in the presence of chloroquine,
instead of diffuse fluorescence which was seen in the
absence of chloroquine, because acid-induced fusion
of the liposome with endosomal membrane does not
w xoccur in the former case 34 . However, in this study
we observed significant reduction of fluorescence
intensity of calcein instead of generation of vesicular
fluorescence they observed. This is possibly due to
difference in stability of these liposomes. In fact, a
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large part of EYPC liposomes were still not degraded
in the cell after 3 h-incubation even in the absence of
chloroquine as shown below. Therefore, it is likely
that in the presence of chloroquine the polymer-mod-
ified liposomes retain the content in their inside.
Similar effect was seen when the cells were treated
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 .  .Fig. 7. Fluorescence emission spectra of EYPCrSucPG 7:3, wrw liposomes containing NBD-PE and Rh-PE: A emission spectra of
 .  .  .the starting liposome; B the liposome solubilized by adding Triton X-100 final concentration: 0.24% ; C the liposome-treated cells.
lex: 450 nm. The cell-liposome incubation was performed in phosphate-buffered saline containing calcium and magnesium for 3 h at
378C. The concentration of liposomal lipid in the incubation was 1.0 mM.
with the liposomes in the presence of ammonium
chloride, which is also known to increase the endoso-
w x  .mal pH 35 result not shown .
In order to confirm the occurrence of fusion be-
tween SucPG-modified liposomes and the endosomal
andror lysosomal membranes, fusion assay by reso-
w xnance energy transfer was performed 28 . The lipo-
somes containing NBD-PE and Rh-PE were prepared
and CV-1 cells were incubated with the liposomes.
Fig. 6 represents fluorescence and phase contrast
micrographs of the cells treated with the liposomes
containing the fluorescent lipids when NBD-PE was
 .excited lex: 470–500 nm . These fluorescence mi-
crographs reveal striking difference. In the cells
treated with bare EYPC liposome displays vesicular,
red fluorescence, namely fluorescence of Rh-PE, in-
dicating that in a large fraction of liposomes energy
transfer from NBD-PE to Rh-PE occurs efficiently.
This suggests that most liposomes are still intact even
after 3 h incubation. In contrast, vesicular, yellow
 .  .  .Fig. 5. Fluorescence micrograph left and phase contrast micrograph right of CV-1 cells treated with EYPCrSucPG 7:3, wrw
liposome containing calcein. The cell-liposome incubation was performed in phosphate-buffered saline containing calcium and
magnesium for 3 h at 378C in the presence of 0.2 mM chloroquine. The concentration of liposomal lipid in the incubation was 1.5 mM.
Time of exposure to photographic film for the fluorescence micrograph was 31 s.
 .  .Fig. 6. Fluorescence micrographs left and phase contrast micrographs right of CV-1 cells treated with various liposomes containing
 .  .  .  .NBD-PE and Rh-PE: A bare EYPC liposome; B and C EYPCrSucPG 7:3, wrw liposome. The cell-liposome incubation was
 .  . performed in phosphate-buffered saline containing calcium and magnesium in the absence A and B or presence C of chloroquine 0.2
.mM for 3 h at 378C. The concentration of liposomal lipid in the incubation was 1.5 mM. Time of exposure to photographic film for these
fluorescence micrographs was 11 s.
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fluorescence, namely fluorescence of NBD-PE, can
be seen in the cells treated with SucPG-modified
liposome. In this case most liposomes are considered
to fuse with cellular membranes andror degraded in
the cells. When incubation was performed in the
presence of chloroquine, apparently fluorescence of
Rh-PE is enhanced in the cells, compared to the cell
treated in the absence of chloroquine, indicating that
fusion and degradation of the polymer-modified lipo-
somes are partly inhibited in the presence of chloro-
quine. This is consistent with the result of the lipo-
some-mediated calcein delivery.
As is seen in Fig. 2, when the cells were treated
with the calcein-loaded polymer-modified liposomes,
the cells displayed diffuse fluorescence. However,
when the liposomal membrane was labeled with the
fluorescent lipids, vesicular fluorescence was ob-
served in the liposome-treated cells. This result indi-
cates that sites where the liposome content exists and
where the liposomal lipid exists are different. It is
considered that the liposomal lipids exist mainly in
endosome andror lysosome.
For quantitative estimation of fusion, emission
spectra of the liposome-treated cells were investi-
gated. Fig. 7 shows fluorescence emission spectra of
 .the starting liposomes A , the liposomes solubilized
 .by adding Triton X-100 B , and the liposome-treated
 .cells C . Apparently, increase of NBD-PE fluores-
cence near 520 nm and decrease of Rh-PE fluores-
cence near 585 nm can bee seen in the spectrum of
the liposome-treated cells, compared to that of the
starting liposomes. This change of the spectrum indi-
cates reduction of surface density of NBD-PE and
Rh-PE in the membranes, compared to that of the
starting liposomes.
We assumed that there are two distinct fractions of
the liposomes existing in the liposome-treated cells,
namely the liposomes fused and those not fused with
cellular membranes. When the liposome fuses with a
cellular membrane, the liposome-derived lipids can
freely intermix with those present in the cellular
membrane and hence, efficiency of resonance energy
transfer between NBD-PE and Rh-PE will decrease
significantly. Therefore, these fluorescent lipids de-
rived from the fused liposomes will reveal the fluo-
rescence spectrum shown in Fig. 7B. Some portion of
the liposomes taken up by the cells may be degraded
in lysosome. The fluorescent probes derived from the
Table 1
Fraction of liposome fused andror degraded in cell
Liposome Fraction
EYPC 0.31"0.01
 .EYPCrSucPG 9:1, wrw 0.68"0.01
 .EYPCrSucPG 8:2, wrw 0.74"0.01
 .EYPCrSucPG 7:3, wrw 0.78"0.02
After 3 h incubation in PBS containing Ca2q and Mg2q. The
experiments were done in duplicate.
degraded liposomes also might give the same spec-
trum. In contrast, the fluorescence lipids existing in
the intact liposomes show the spectrum depicted in
Fig. 7A.
Because the spectrum shown in Fig. 7C is consid-
ered to consist of the spectra shown in Fig. 7A and B,
it is possible to estimate fraction of the liposomes
fused or degraded in the cells. Fraction of fused or
degraded liposome in the liposome-treated cells eval-
uated via the above procedure is listed in Table 1.
Although bare EYPC liposome is not fusogenic, fused
or degraded fraction was estimated to be 0.31 possi-
bly because of degradation of liposomal lipids. How-
ever, the polymer-modified liposomes show consider-
ably higher values, compared to bare liposome.
Moreover, the liposome with a higher polymer con-
tent reveals a higher value. These values are thought
to contain fraction of liposomes not fused but de-
graded. However, degradation of lipid of these lipo-
somes might equally occur in the cells. Thus, this
result suggests the liposome with a higher amount of
the polymer fuses more easily with cellular mem-
branes.
While so far pH-sensitive liposomes have been
considered to deliver their contents into cytoplasm by
w xliposome-endosome fusion 3 , it is implied that
SucPG-modified liposomes also transfer the content
via the same mechanism by considering the following
 .facts: 1 delivery of calcein by the liposomes was
 .interfered by addition of chloroquine, 2 significant
intermixing of lipids occurred between the liposomes
 .and endosome andror lysosome, 3 efficiency of
delivery is correlated with fusion ability of the lipo-
 .somes, 4 calcein was transferred into cytoplasm,
whereas liposomal lipids existed in endosome andror
lysosome.
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Recently, Vogel et al. reported that EYPC lipo-
somes containing an amphipathic peptide, EALA,
deliver a fluorescent dye into cytoplasm by interact-
ing with endosomal membranes after internalization
w xinto KB cells 15 . They observed that fluorescence
intensity of the dye seen in the liposome-treated cells
increased gradually with time. The fluorescence in
the cytoplasm was weak within 6 h, but increased
continuously with time for more than 48 h. In this
study, we observed that overnight incubation of the
liposome-treated cells hardly affected intensity of the
fluorescence in the cells. Moreover, as shown in
Table 1, a large fraction of the SucPG-modified
liposomes was already fused after 3 h-incubation.
These facts imply that SucPG-modified liposomes
may be able to achieve faster cytoplasmic delivery.
In conclusion, it was found that the SucPG-mod-
ified EYPC liposomes can transfer their content into
cytoplasm by fusing with endosomal andror lysoso-
mal membranes. Efficiency of delivery mediated by
the polymer-modified liposomes was shown to be
elevated as the polymer content of the liposome
increases. In this polymer-liposome system various
kinds of lipids can be used as membrane components.
In this study we used EYPC, which forms a stable
bilayer membrane, as a liposomal lipid. However, if
unsaturated PE is added as an additional membrane
component, fusion ability of the liposomes is ex-
pected to increase. Also, conjugation of ligands or
antibodies, which bind their receptors or antigens
existing on the cell surface, to the polymer-modified
liposomes is possible by using carboxyl groups on
the polymer. Such conjugation will give the lipo-
somes with target specificity. When an appropriate
ligand which is internalized into endosome after bind-
ing to its receptor is combined to the liposomes, more
efficient delivery is expected to be achieved. There-
fore, this polymer-liposome system might have poten-
tial usefulness as a cytoplasmic delivery system with
high stability and high efficiency.
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